2020 (v1)
Publication
No description
Uploaded on: March 27, 2023
P
P
Last name: PANIZZA
First name: Pietro
No description
The introduction of PARP inhibitors has revolutionized the management and treatment of patients with pathogenic germline variants of BRCA1/2 who have developed breast cancer. The implementation of PARP inhibitors in clinical settings can be challenging due to their overlapping indications with other drugs, including both recently approved...